In response to the yellow fever outbreak in late 2023, the Republic of South Sudan's Ministry of Health announced today that it has initiated a reactive yellow fever vaccination campaign as a preventive response intervention.
As of February 3, 2024, 48 suspected and two confirmed yellow fever cases were reported from Yambio, Nzara, Tambura, Ibba, Ezo, and Maridi Counties of Western Equatoria State.
610,000 Individuals Receiving Yellow Fever Vaccine in South Sudan
Do Antibodies Help Vaccines Protect Against Herpes
A recent study conducted by researchers at Dartmouth's Geisel School of Medicine and Thayer School of Engineering has shed light on the role of antibodies in fighting herpes simplex virus (HSV) infections.
These findings, published in Cell Reports Medicine on February 12, 2024, could pave the way for new treatments or vaccines for neonatal herpes.
In their experiments, the research team used a neonatal mouse model to mimic human neonatal infections, engineering antibodies with different properties to explore how they mediate protection.
Frexalimab Has Favorable Effect on Relapsing Multiple Sclerosis
Generally favorable effect seen in terms of number of new gadolinium-enhancing T1-weighted lesions at week 12
Prepandemic Physical Activity Tied to COVID-19 Diagnosis
In addition to lower risk for infections, sufficient physical activity tied to lower hospitalization